Your session is about to expire
← Back to Search
Levetiracetam for Alzheimer's Disease (LAPSE Trial)
LAPSE Trial Summary
This trial will study whether or not treating seizures can improve neuro-psychiatric symptoms in Alzheimer's patients.
LAPSE Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2006 Phase 4 trial • 251 Patients • NCT00160654LAPSE Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You are not expected to live for more than 12 months.I have had encephalitis or meningitis in the past.I have been diagnosed with epilepsy.I had major depression or behavioral issues before my Alzheimer's diagnosis.My current medications have been the same for at least 4 weeks.I have had a head injury that made me unconscious for over 30 minutes.I have taken anti-epileptic medication in the last 3 months.You have a history of alcohol or drug abuse within the last 5 years.I am not pregnant, breastfeeding, nor planning to become pregnant during the trial.You have been diagnosed with Alzheimer's disease according to specific criteria.I have a history of Korsakoff's syndrome.I have surgery planned that will need general anesthesia during the trial.My cancer needs chemotherapy now.I do not have conditions like severe kidney, liver issues, or untreated vitamin deficiencies that could explain my memory problems.You have had an allergic reaction to levetiracetam in the past.Your memory and thinking skills score is less than 26.Your MRI scan doesn't show any signs of possible seizure spots.You have a score of 4 or higher on the Twelve-item Neuropsychiatric Inventory.My scans show possible reasons for seizures or memory loss.
- Group 1: Levetiracetam
- All Individual Drugs Already Approved - Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
- Approved for 5 Other Conditions - This treatment demonstrated efficacy for 5 other conditions.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there any risks associated with the administration of Levetiracetam?
"Leveraging existing clinical research, our team at Power has assigned Levetiracetam a score of two on the safety scale as this is currently in Phase 2. There are prelimary reports detailing its safety but no efficacy data yet."
Is the enrollment stage of this research endeavor currently accepting participants?
"This research has ceased participant recruitment. It was initially listed on January 1st 2020 and modified lastly on June 27th 2019. If you are searching for other studies, there are currently 780 clinical trials actively recruiting patients with Alzheimer's disease and 18 trials exploring Levetiracetam which require participants."
Has Levetiracetam previously been investigated in prior research?
"Currently, 18 medical trials involving Levetiracetam are underway with 2 of them in the final phase. The bulk of these studies occur at research centres located in Brisbane, Queensland; however, there are 40 sites overall carrying out such studies."
To what extent is Levetiracetam used to treat medical conditions?
"Levetiracetam is employed in clinical settings to treat juvenile myoclonic epilepsy, as well as a range of other medical issues including epilepsies and myoclonic seizures for individuals with body masses that exceed 20 kilograms."
How many participants are currently accepted for this clinical research?
"Unfortunately, no further recruitment is being conducted for this trial. The initial posting was on January 1st 2020 and the last update was June 27th 2019. As an alternative, there are currently 780 research projects recruiting individuals with Alzheimer's disease and 18 studies that require volunteers to take Levetiracetam."
Who else is applying?
What state do they live in?
How old are they?
What portion of applicants met pre-screening criteria?
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger